ODTX (Odyssey Therapeutics, Inc. Common Stock) Stock Analysis - News
Odyssey Therapeutics, Inc. Common Stock (ODTX) is a publicly traded the market company. As of May 21, 2026, ODTX trades at $16.98 with a market cap of $820.36M and a P/E ratio of 0.00. ODTX moved +0.35% today. Year to date, ODTX is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $15.35 to $20.30. Rallies surfaces ODTX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
What changed in ODTX news today?
Healthcare IPOs Raise $4.7B as Odyssey Therapeutics and Mobia Debuts Underperform: Healthcare IPOs raised $4.7B as Odyssey Therapeutics and Mobia shares debuted below their offer prices on the first trading day. Despite the sizable proceeds, both stocks slipped after listing, highlighting investor caution toward new clinical-stage healthcare issues.
TPG GP A, LLC bought 1.39M (~$25.00M) on May 11, 2026.
SR ONE CAPITAL MANAGEMENT, LLC sold 1.06K (~$19.17K) on May 11, 2026.
SR ONE CAPITAL MANAGEMENT, LLC bought 222.22K (~$4.00M) on May 11, 2026.
ODTX Analyst Consensus
ODTX analyst coverage data. Average price target: $0.00.
Common questions about ODTX
What changed in ODTX news today?
Healthcare IPOs Raise $4.7B as Odyssey Therapeutics and Mobia Debuts Underperform: Healthcare IPOs raised $4.7B as Odyssey Therapeutics and Mobia shares debuted below their offer prices on the first trading day. Despite the sizable proceeds, both stocks slipped after listing, highlighting investor caution toward new clinical-stage healthcare issues.
Does Rallies summarize ODTX news?
Yes. Rallies summarizes ODTX news with ticker-specific context, catalysts, source links, and AI-generated market summaries when news is available.
Is ODTX research on Rallies investment advice?
No. Rallies provides research, data, and educational context for ODTX. It does not provide personalized investment advice.
